<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-09T12:52:06Z</responseDate>
  <request identifier="oai:figshare.com:article/33938889" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33938889</identifier>
        <datestamp>2026-09-18T17:44:11Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;TPT surge data.&lt;/p&gt;</dc:title>
          <dc:creator>Phallon Blessing Mwaba (25073412)</dc:creator>
          <dc:creator>Innocent Mwaba (18158388)</dc:creator>
          <dc:creator>Minyoi Mubita Maimbolwa (18137037)</dc:creator>
          <dc:creator>Chitalu Chanda (21354901)</dc:creator>
          <dc:creator>Muhammad Mputu (24559881)</dc:creator>
          <dc:creator>Chola Lumbwe (25073415)</dc:creator>
          <dc:creator>Kevin Zimba (25073418)</dc:creator>
          <dc:creator>Nancy Kasese Chanda (25073421)</dc:creator>
          <dc:creator>Rhehab Chimzizi (41700)</dc:creator>
          <dc:creator>Angel Mubanga (19670074)</dc:creator>
          <dc:creator>Monde Muyoyeta (372849)</dc:creator>
          <dc:creator>Mary Kagujje (9362116)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>tuberculosis preventive therapy</dc:subject>
          <dc:subject>thorough planning phase</dc:subject>
          <dc:subject>present programme data</dc:subject>
          <dc:subject>analyzed aggregate data</dc:subject>
          <dc:subject>4226 ); one</dc:subject>
          <dc:subject>reduce tb incidence</dc:subject>
          <dc:subject>national tb programme</dc:subject>
          <dc:subject>th &lt;/ sup</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>despite evidence showing</dc:subject>
          <dc:subject>based tpt initiation</dc:subject>
          <dc:subject>89 high tb</dc:subject>
          <dc:subject>5 %, n</dc:subject>
          <dc:subject>uptake among hiv</dc:subject>
          <dc:subject>negative tb contacts</dc:subject>
          <dc:subject>eligible household contacts</dc:subject>
          <dc:subject>tpt surge aimed</dc:subject>
          <dc:subject>zambia &lt;/ p</dc:subject>
          <dc:subject>7 %, n</dc:subject>
          <dc:subject>2 %, n</dc:subject>
          <dc:subject>tb contacts</dc:subject>
          <dc:subject>negative contacts</dc:subject>
          <dc:subject>negative individuals</dc:subject>
          <dc:subject>treatment due</dc:subject>
          <dc:subject>targeted implementation</dc:subject>
          <dc:subject>surge demonstrated</dc:subject>
          <dc:subject>stakeholder engagement</dc:subject>
          <dc:subject>programmatic rollout</dc:subject>
          <dc:subject>preferred regimen</dc:subject>
          <dc:subject>points increase</dc:subject>
          <dc:subject>months isoniazid</dc:subject>
          <dc:subject>month isoniazid</dc:subject>
          <dc:subject>january 2025</dc:subject>
          <dc:subject>immediate 47</dc:subject>
          <dc:subject>findings underscore</dc:subject>
          <dc:subject>facility registers</dc:subject>
          <dc:subject>driven approaches</dc:subject>
          <dc:subject>contact tracing</dc:subject>
          <dc:subject>232 ).</dc:subject>
          <dc:subject>001 ).</dc:subject>
          <dc:subject>&amp;# 8211</dc:subject>
          <dc:description>&lt;div&gt;&lt;p&gt;While tuberculosis preventive therapy (TPT) coverage among people living with HIV in Zambia has improved, uptake among HIV-negative contacts aged ≥5 years remains low. Despite evidence showing that TPT can reduce TB incidence by up to 60% in HIV-negative individuals, there is a paucity of evidence on programmatic rollout to this population in Zambia and the region. We present programme data from a TPT surge aimed at increasing uptake among ≥5 years old HIV-negative household TB contacts. The National TB Programme, with support from the TB Local Organizations Network, conducted a TPT surge in 89 high TB-burden facilities across eight project supported provinces in Zambia from October 2024–15&lt;sup&gt;th&lt;/sup&gt; January 2025. After a thorough planning phase, multidisciplinary teams conducted field visits for contact tracing and initiated TPT for eligible household contacts of bacteriologically confirmed TB.. Facility-based TPT initiation was provided for walk-in clients. We collected and analyzed aggregate data from facility registers. A total of 19,371 HIV-negative contacts aged ≥ 5 years were screened: 99.9% (n = 19,344) were eligible for and offered TPT. Of these, 72.4% (n = 14,000) were initiated on TPT, 2.0% (n = 385) refused and 26.2% (n = 4,959) were not initiated on treatment due to unavailability of their preferred regimen. The start of the surge was associated with an immediate 47.7% points increase in TPT coverage (p = 0.001). Overall, 63.7% (n = 8,917) were initiated on three-months Isoniazid+Rifapentine, followed by six-months Isoniazid (30.2%, n = 4226); one-month Isoniazid+Rifapentine (4.5%, n = 625) and on three-months Isoniazid+Rifampicin (1.7%, n = 232). The surge demonstrated that TPT can be rolled out to ≥5 years old HIV-negative TB contacts with high initiation rates achieved. This is achievable through targeted implementation, stakeholder engagement, and community-driven approaches. These findings underscore the feasibility of extending TPT to all TB contacts, regardless of HIV status or age, to accelerate TB prevention efforts in high-burden settings like Zambia.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-09-18T17:44:08Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pgph.0005628.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_TPT_surge_data_p_/33938889</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
